BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15127371)

  • 1. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant Streptococcus pneumoniae.
    Campbell GD; Silberman R
    Clin Infect Dis; 1998 May; 26(5):1188-95. PubMed ID: 9597251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
    Bédos JP; Bruneel F
    Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance among Streptococcus pneumoniae: Implications for drug selection.
    Appelbaum PC
    Clin Infect Dis; 2002 Jun; 34(12):1613-20. PubMed ID: 12032897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD
    Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial resistance profile of Streptococcus pneumoniae.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal resistance in the postvaccine era.
    Temime L; Guillemot D; Boëlle PY
    Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal drug resistance: the new "special enemy of old age".
    Butler JC; Cetron MS
    Clin Infect Dis; 1999 Apr; 28(4):730-5. PubMed ID: 10825028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm.
    Dagan R; Barkai G; Leibovitz E; Dreifuss E; Greenberg D
    Pediatr Infect Dis J; 2006 Oct; 25(10):981-6. PubMed ID: 17006311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
    Doern GV
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
    Low DE
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.